Vegetable Laxative And Stool Softner Tablet, Coated
NDC Package 36800-938-60
Package Information
Vegetable Laxative And Stool Softner (docusate sodium and sennosides) tablets is take preferably at bedtime or as directed by a doctorAgeStarting DosageMaximum Dosageadults and children 12 years and over2 tablets once a day4 tablets twice a daychildren 6 to under 12 years1 tablet once a day2 tablets twice a daychildren 2 to under 6 years½ tablet once a day1 tablet twice a daychildren under 2 yearsask a doctorask a doctor. This formulation utilizes a tablet, coated delivery system. Marketed by Topco Associates Llc, this product is identified by NDC 36800-938 and is authorized under FDA application M007.
Identification & Billing
- RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
- RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
- RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 36800 - Topco Associates Llc
- 36800-938 - Vegetable Laxative And Stool Softner
- 36800-938-60 - 1 BOTTLE in 1 CARTON / 60 TABLET, COATED in 1 BOTTLE
- 36800-938 - Vegetable Laxative And Stool Softner
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 36800-938-60 identifies a specific commercial package of 1 bottle in 1 carton / 60 tablet, coated in 1 bottle of Vegetable Laxative And Stool Softner, a human over the counter drug labeled by Topco Associates Llc. This tablet, coated is formulated for oral use and contains docusate sodium; sennosides as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Topco Associates Llc on May 01, 2021. The current certification is valid through December 31, 2026.
How is this Topco Associates Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 36800093860. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.